Analysts Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Price Target at $94.36

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned an average rating of “Moderate Buy” from the fifteen analysts that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $94.36.

Several equities analysts recently commented on the company. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. Stifel Nicolaus boosted their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. Evercore ISI increased their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Finally, JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target on the stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $81.76 on Thursday. The company has a 50-day simple moving average of $88.70 and a 200-day simple moving average of $83.48. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a market cap of $37.35 billion, a PE ratio of 22.46, a price-to-earnings-growth ratio of 3.02 and a beta of 1.24. GE HealthCare Technologies has a 12 month low of $66.39 and a 12 month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. During the same period in the previous year, the company earned $0.99 EPS. GE HealthCare Technologies’s revenue for the quarter was up .9% on a year-over-year basis. On average, equities analysts anticipate that GE HealthCare Technologies will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date was Friday, October 18th. GE HealthCare Technologies’s payout ratio is 3.30%.

Insider Activity

In other news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.27% of the company’s stock.

Hedge Funds Weigh In On GE HealthCare Technologies

Institutional investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 7.2% during the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company’s stock valued at $1,026,898,000 after acquiring an additional 733,819 shares in the last quarter. M&T Bank Corp grew its stake in GE HealthCare Technologies by 0.7% during the 3rd quarter. M&T Bank Corp now owns 37,330 shares of the company’s stock valued at $3,504,000 after purchasing an additional 276 shares in the last quarter. Continuum Advisory LLC increased its holdings in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in GE HealthCare Technologies by 7.1% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 188,431 shares of the company’s stock worth $17,684,000 after purchasing an additional 12,510 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its position in shares of GE HealthCare Technologies by 9.7% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company’s stock valued at $13,702,000 after purchasing an additional 12,908 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.